Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Anti-Helicobacter agents from Janssen

March 15, 1996

Fibrinogen antagonists from E. Merck

March 15, 1996

Class III antiarrhythmics from Mitsui Toatsu

March 15, 1996

Potassium channel openers from Nippon Kayaku

March 15, 1996

Ciba-Geigy claims renin inhibitors

March 15, 1996

Kyowa Hakko reports endothelin antagonists

March 15, 1996

Terumo TxA2/LTD4 antagonists for asthma

March 15, 1996

Fujisawa claims PDE IV/TNF inhibitors

March 15, 1996

Alpha2-adrenoceptor antagonists with neuroprotective effects

March 15, 1996

Astra antioxidants for hypoxia

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...